Literature DB >> 6180880

[Yttrium-90-therapy of bone metastases].

J Kutzner, W Grimm, K H Brod, A Roesler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6180880     DOI： 10.1055/s-2008-1070131

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN： 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  3 in total

1.  Results of a double blind study of 89-strontium therapy of skeletal metastases of prostatic carcinoma.

Authors:  K Buchali; H J Correns; M Schuerer; D Schnorr; H Lips; K Sydow
Journal:  Eur J Nucl Med       Date:  1988

2.  The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain.

Authors:  Knut Liepe; Roswitha Runge; Jörg Kotzerke
Journal:  J Cancer Res Clin Oncol       Date:  2004-09-22       Impact factor: 4.553

Review 3.  Radionuclide therapy revisited.

Authors:  C A Hoefnagel
Journal:  Eur J Nucl Med       Date:  1991
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.